Genetic polymorphisms of angiotensin-I converting enzyme, haptoglobin and angiotensinogen and oxidative stress parameters in 12 to 15-year-old adolescents;Polimorfismos genéticos da enzima conversora da angiotensina-I (ECA), haptoglobina (HP) e angiotensinogénio (AGT) e parâmetros de sobrecarga oxidante, em adolescentes de 12-15 anos de idade

Revista Portuguesa de Cardiologia

Volumn 25, Issue 7-8, 2006, Pages 677-690

  Coelho, Constança ^b   Guerra, António ^b   Rego, Carla ^b   Breitenfeld, Luíza ^b   Castro, Elisabete ^b   Rodrigues, Paulino ^b   Laires, Maria José ^b   Bicho, Manuel ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b NONE

Author keywords

ACE; AGT; Blood pressure; Cardiovascular risk factors; Hp; Oxidative stress

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ANGIOTENSINOGEN; APOLIPOPROTEIN B; BIOCHEMICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE; HAPTOGLOBIN; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; AGE DISTRIBUTION; ALLELE; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRESCHOOL CHILD; RISK FACTOR; SOMATIC CELL GENETICS; SPECTROPHOTOMETRY;

ADOLESCENT; ANGIOTENSINOGEN; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HAPTOGLOBINS; HUMANS; MALE; OXIDATIVE STRESS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 33749609325     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Berenson GS, McMahan CA, Voors AW. Cardiovascular Risk Factors in Children - The Early Natural History of Atherosclerosis and Essential Hypertension. New York: Oxford University Press, 1980.
2. International task force for prevention of coronary heart disease. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutr Metab Cardiovasc Dis 1992;2:113-56.
3. Lenfant C, Savage PJ. The early natural history of atherosclerosis and hypertension in the young: National Institutes of Health Perspectives. Am J Med Sci 1995;310 (Suppl 1):3-7.
4. Raitakari OT, Porkka KVK, Rasanen L, Ronnemaa T, Viikari JSA. Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults: the cardiovascular risk in young Finns study. J Clin Epidem 1994;47:1085-93.
5. Study Group EAS. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J 1987;8:77-88.
6. Vobecky JS, Grant AM, Laplante P, David P, Vobecky J. Hypercholesterolaemia in childhood: repercussions in adulthood. Eur J Clin Nutr 1993;47(Suppl 1):47-56.
7. Lecerf JM, Luc G, Fruchart JC. Antioxidants et athérosclé rose. Méd et Nut 1996;32:8-15.
8. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
9. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000 May;101:2206-12.
10. Dobryszycka W. Biological functions of haptoglobin - new pieces to an old puzzle. Eur J Clin Chem Clin Biochem 1997 Sept.;35:647-54.
11. Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987;917:219-23.
12. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990;280:1-8.
13. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-81.
14. Tribble DL, van den Berg JJ, Motchnik PA, Ames BN, Lewis DM, Chait A, Krauss RM. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. Proc Natl Acad Sci U S A 1994;91:1183-7.
15. Gomez-Diaz C, Rodriguez-Aguilera JC, Barroso MP, Villalba JM, Navarro F, Crane FL, Navas P. Antioxidant ascorbate is stabilized by NADH-coenzyme Q10 reductase in the plasma membrane. J Bioenerg Biomembr 1997;29:251-7.
16. Guerra A, Rego C, Laires MJ, Castro EM, Silva D, Monteiro C, Silva Z, Lebre E, Bicho M. Lipid profile and redox status in high performance rhythmic female teenagers gymnasts. J Sports Med Phys Fitness 2001;41:505-12.
17. Mendiratta S, Qu Z-C, May JM. Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med 1998;24:789-97.
18. Kurtz TW, Spence MA. Genetics of essential hypertension. Am J Med 1993;94:77-84.
19. Bicho MP. Genetic Aspects of Heart Failure. In: Luis Meneses Falcão, Peter A van Zwieten, editors. Current Diagnosis and Treatment in Heart Failure. Lisboa: Publ. Lidel, 2001:51-8.
20. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-76.
21. Delanghe JR, Duprez DA, de Buyzere ML, Bergez BM, Claeys LR, Leroux-Roels GG, Clement DL. Refractory hypertension is associated with the haptoglobin 2-2 phenotype. J Cardiovasc Risk 1995;2:131-6.
22. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93:1285-7.
23. eunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
24. Kojima S, Inenaga T, Matsuoka H, Kuramochi M, Omae T, Nara Y, Yamori Y. The association between salt sensitivity of blood pressure and some polymorphic factors. J Hypertens 1994;12:797-801.
25. Ledru F, Blanchard D, Battaglia S, Jeunemaitre X, Courbon D, Guize L, Germonprez J-L, Ducimetiere P, Diébold B. Relation between severity of coronary artery disease, left ventricular function and myocardial infarction, and influence of the ACE I/D gene polymorphism. Am J Cardiol 1998;82:160-5.
26. Langlois MR, Delanghe JR, de Buyzere ML, Bernard DR, Ouyang J. Effect of haptoglobin on the metabolism of vitamin C. Am J Clin Nutr 1997;66:606-10.
27. Langlois MR, Martin ME, Boelaert JR, Beaumont C, Taes YE, de Buyzere ML, Bernard DR, Neels HM, Delanghe JR. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin Chem 2000;46:1619-25.
28. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Miki T, Mikami H, Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun 1993;191:399-404.
29. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, Lalouel JM. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997;60:1448-60.
30. Jelliffe DB, Jelliffe EFP. Direct assessment of nutritional status. Anthropometry: major measurements. In: Jelliffe DB, Jelliffe EFP, editors. Community Nutritional Assessment with special reference to less technically developed countries. New York: Oxford University Press, 1989:68-105.
31. Lee J, Kolonel LN, Hinds W. Relative merits of the weight-corrected-for- height indices. Am J Clin Nutr 1981;34:2521-9.
32. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-29.
33. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 1991;145:259-63.
34. Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status. 4th ed. The University of Michigan Press, 1993.
35. Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH: Recommendations for human blood pressure determination by sphygmomanometers: report of a special task force appointed by the steering committee. American Heart Association. Circulation 1988;77:A501-A514.
36. Report of the second Task Force on blood pressure control in children. Pediatrics 1987;79:1-25.
37. Alain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
38. Flegg HM. An investigation of the determination of serum cholesterol by an enzymatic method. Am Clin Biochem 1973;10:79.
39. Lindgren FT, Jensen LC, Hatch FT. In: Nelson GJ, Wiley J, editors. Blood lipids and lipoproteins. New York: Interscience, 1972:181-274.
40. Manual of laboratory operations. Lipid Research Clinics Program: Lipid and lipoprotein analysis. US Department of Health Education and Welfare Pub. (NIH), 1974.
41. Linke RP. Typing and subtyping of haptoglobin from native serum using disc gel electrophoresis in alkaline buffer: application to routine screening. Anal Biochem 1984;141:55-61.
42. Faure-Delanef L, Baudin B, Beneteau-Burnat B, Beaudoin JC, Giboudeau J, Cohen D. Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians. Clin Chem 1998;44:2083-7.
43. Rabini RA, Fumelli P, Galassi R, Dousset N, Taus M, Ferretti G, Mazzanti L, Curatola G, Solera ML, Valdiguie P. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. Metabolism 1994;43:1470-4.
44. Clara JG, Coelho C, Breitenfeld L, Siqueira C, Bicho MP, de Pádua F. Acute effects of tobacco and vascular risk modulated by genetic factors. Rev Port Cardiol 2000;19:1279-83.
45. Danser AHJ, Osterop APRM, Deinum J, Schalekamp MADH. No difference in regional angiotensin-II conversion in subjects of different angiotensin- converting enzyme genotypes. J Hypertens 1999;17(Suppl 3):S166.
46. Pei Y, Scholey J, Thai K, Suzuki M, Cattran D. Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest 1997;100:814-20.
47. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996;58:1268-78.
48. Stankovic A, Zivkovic M, Alavantic D. Angiotensin I-converting enzyme gene polymorphism in a Serbian population: a gender-specific association with hypertension. Scand J Clin Lab Invest 2002;62:469-75.
49. Chen L-M, Chung P, Chao S, Chao L, Chao J. Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochim Biophys Acta 1992;1131:145-51.
50. Nathan DF, Lindquist S. Mutational Analysis of Hsp90 Function: Interactions with a Steroid Receptor and a Protein Kinase. Mol Cel Biol 1995;15:3917-25.
51. Park J-W, Means GE. Inactivation of angiotensin converting enzyme by sodium nitroprusside. Biochem Biophys Res Commun 1987;145:1048-53.
52. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann Rev Pharmacol Toxicol 1990;30:535-60.
53. Weinberger MH, Miller JZ, Fineberg NS, Luft FC, Grim CE, Christian JC. Association of haptoglobin with sodium sensitivity and resistance of blood pressure. Hypertension 1987;10:443-6.
54. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q, Taylor, WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997;80:45-51.